Pages
A huge thank you to colleagues who helped us raise more than £2,000 for local hospices
https://dchs.nhs.uk/news/huge-thank-you-colleagues-who-helped-us-raise-more-2000-local-hospices
DCHS inclusion conference 2023
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/dchs-inclusion-conference-2023
Logging compliments – new system
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/logging-compliments-new-system
Alan Blair’s retirement
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/alan-blairs-retirement
Files
Disclosure Ref 2025280 - Individuals who should have paid for secondary healthcare who were referred to the Home Office.doc
Freedom of information disclosure relating to individuals who should have paid for secondary healthcare who were referred to the Home Office
Mortons Neuroma Care Pathway (G76)
G76 - Mortons Neuroma Care Pathway
Mandatory Covid 19 Vaccination FAQs DCHS_v1.2_27.01.22
Mandatory Covid 19 Vaccination FAQs (DCHS) updated 27 January 2022, answers to your queries about mandatory staff covid-19 vaccinations
Appendix 3 – Royal College of Physicians ‘How to measure lying and standing blood pressure as part of a falls assessment (P32)
Royal College of Physicians How to measure lying and standing blood pressure as part of a falls assessment
Metatarsalgia (Pain in ball of foot) - Weil - Schwartz Osteotomy (L19)
Metatarsalgia (Pain in ball of foot) - Weil - Schwartz Osteotomy. Podiatric Surgery patient information leaflet.
TPP264-0280 - Controlled Drug Schedule 2 Stock Balance Sheet for CRT/Rapid Response Carers
TPP264-0280 - Controlled Drug Schedule 2 Stock Balance Sheet for CRT/Rapid Response Carers
Medical Adhesive Skin Related Injury (MARSI) Tool (G255)
G255 - Medical Adhesive Skin Related Injury (MARSI) Tool
Podiatry Assistant Role Protocol for Podiatrists (S107)
The purpose of this document is to provide guidance on the delegation of podiatry care to a podiatry assistant.
Guidance for E-referrals via S1 to the Tissue Viability Service (G327)
Guidance for E-referrals via S1 to the Tissue Viability Service
Disclosure Ref 2024111 - Framework Agency Spend Jun 2023 to Mar 24 1 of 2.pdf
Disclosure Ref 2024111 - Framework Agency Spend Jun 2023 to Mar 24 1 of 2